Insulin Glargine Latest News
Links shared publicly online about this topic
Pediatrics Medical News about glargine insulin
mdlinx.com — “Is bedtime supper necessary for older children with diabetes using glargine insulin in multiple daily injection regimens” View full resource at mdlinx.com
Most Recently Shared on February 15, 2010 at 12:30 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Peds: Is bedtime supper necessary for older children with diabetes using glargine insulin in multiple daily inject... http://bit.ly/a1oA2O
Study to determine link between insulin glargine and cancer
news-medical.net — “Type 2 diabetes and obesity are linked to an increased risk of certain cancers. Recently published studies suggested that insulin glargine (a synthetic insulin preparation marketed under the trade name Lantus), may be associated with a higher risk of certain cancers than other insulins or oral glucose lowering medications. However, these studies were unable to control for important factors such as obesity that may have driven the association.” View full resource at news-medical.net
Most Recently Shared on December 15, 2009 at 6:58 pm By:
Obesity News: Study to determine link between insulin glargine and cancer: Type 2 diabetes and obesity are linked... http://twurl.nl/bn1x0l
LANTUS (Insulin glargine) drug information from MPR
empr.com — “LANTUS (Insulin glargine) drug information for Diabetes mellitus~hyperglycemic agents from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on April 22, 2011 at 4:28 am By:
MPR News: LANTUS: How supplied: OptiClik cartridge system discontinued. http://bit.ly/hm6Z3B
Latest News and Information on Insulin Pump
diabetesreview.info — “Latest News and Information on Insulin Pump” View full resource at diabetesreview.info
Most Recently Shared on April 28, 2010 at 2:12 pm By:
Insulin pump co Nilimedix signs China deal . http://diabetesreview.info/news/Insulin-pump.html
Medical News: FDA Reviewing Safety Data for Insulin Glargine - in Cardiovascular, Diabetes from MedPage Today
medpagetoday.com — “WASHINGTON -- In light of four recently published studies showing a link between insulin glargine (Lantus) and cancer, the FDA announced it is reviewing safety for the drug, but urged diabetic patien” View full resource at medpagetoday.com
Most Recently Shared on July 1, 2009 at 9:56 pm By:
CARDIOLOGY• FDA Reviewing Safety Data for Insulin Glargine http://tinyurl.com/ms5lx2
Medical News: Mixed Message on Insulin Glargine Cancer Risk - in Cardiovascular, Diabetes from MedPage Today
medpagetoday.com — “HOUSTON -- Studies examining a possible cancer link to insulin glargine (Lantus) produced mixed conclusions that drew quick, reassuring messages from diabetes authorities.” View full resource at medpagetoday.com
Most Recently Shared on June 29, 2009 at 11:49 pm By:
CARDIOLOGY• Mixed Message on Insulin Glargine Cancer Risk (CME/CE) http://tinyurl.com/mq2dup
Exenatide Plus Insulin Glargine Provides Excellent Glucose Control Without Hypoglycemia in Type 2 Diabetes - QualityPoint Technologies
qualitypointtech.net — “Exenatide and optimized insulin glargine provided excellent fasting and postprandial glucose control and weight loss, without an increased risk for hypoglycemia, in patients with type 2 diabetes. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on September 28, 2010 at 7:36 pm By:
Exenatide Plus Insulin Glargine Provides Excellent Glucose Control Without Hypoglycemia in Type 2 Diabetes: Exenat... http://bit.ly/dj8eVQ
FDA Drug Safety Communication: Update to ongoing safety review of Lantus (insulin glargine) and possible risk of cancer - Drugs.com MedNews
drugs.com — “Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals Data Summary References Safety Announcement 1-12-201” View full resource at drugs.com
Most Recently Shared on January 13, 2011 at 1:11 pm By:
Drugs and Devices OW OW Health
FDA Drug Safety Communication: Update to ongoing safety review of Lantus (insulin glargine) and possible r... http://bit.ly/ewUL1F #drug
MD Consult: News: Data suggest possible link between insulin glargine and cancer, but remain inconclusive
mdconsult.com — “MD Consult: News: Data suggest possible link between insulin glargine and cancer, but remain inconclusive” View full resource at mdconsult.com
Most Recently Shared on June 30, 2009 at 10:00 am By:
MD Consult Health Site and Medical Publisher
Data suggest possible link between insulin glargine and cancer, but remain inconclusive http://tinyurl.com/kp757e
Medical News: FDA Okays Byetta Plus Insulin Glargine - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a new indication for the type 2 diabetes drug exenatide (Byetta) as an add-on therapy with insulin glargine, diet, and exercise for adult patients.” View full resource at medpagetoday.com
Most Recently Shared on October 20, 2011 at 6:35 pm By:
FDA okays Byetta plus insulin glargine: http://t.co/SjJfiocG
Endocrine News Now: FDA Completes Preliminary Safety Review of Lantus (insulin glargine)
endocrinenewsnow.org — “Endocrine News Now: FDA Completes Preliminary Safety Review of Lantus (insulin glargine)” View full resource at endocrinenewsnow.org
Most Recently Shared on January 18, 2011 at 4:01 pm By:
TheEndocrineSociety Medical Society
FDA Completes Preliminary Safety Review of Lantus http://www.endocrinenewsnow.org/2011/01/fda-completes-preliminary-safety-review.html
Resistance to Insulin Increased by One Sleepless Night|Healthcare Articles, Health Information And Latest Health News Online
healthmadeeasy.com — “Health Made Easy. Com Provides Medical Health Information, Health And Fitness Articles, Health And Fitness Tips, Health Related Articles, Current Health News, Latest Health Information And More.” View full resource at healthmadeeasy.com
Most Recently Shared on June 16, 2010 at 5:48 pm By:
HealthMadeEasy.com Health Site
Resistance to Insulin Increased by One Sleepless Night - http://tinyurl.com/2cuge64 #Diabetes #Insulin #Health #Sleep
FDA Advisory About Levemir Insulin|Healthcare Articles, Health Information And Latest Health News Online
healthmadeeasy.com — “Health Made Easy. Com Provides Medical Health Information, Health And Fitness Articles, Health And Fitness Tips, Health Related Articles, Current Health News, Latest Health Information And More.” View full resource at healthmadeeasy.com
Most Recently Shared on June 29, 2009 at 6:22 pm By:
HealthMadeEasy.com Health Site
RT @healthmadeeasy: FDA Advisory About Levemir Insulin - http://tinyurl.com/mh2f3r #Diabetes
Ultra-Long-Action Insulin Degludec Comparable to Glargine - QualityPoint Technologies
qualitypointtech.net — “Ultra-long-acting insulin degludec provides comparable glucose control when injected daily or 3 times a week, and with lower rates of hypoglycemia compared with insulin glargine. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on March 11, 2011 at 9:35 pm By:
Ultra-Long-Action Insulin Degludec Comparable to Glargine: Ultra-long-acting insulin degludec provides comparable ... http://bit.ly/dMvll3
Degludec significantly reduces risk of hypoglycaemia during the night compared to insulin glargine in two long-term studies - Drugs.com MedNews
drugs.com — “Novo Nordisk today announced clinical results from two 52-week phase 3a treat-totarget studies comparing Degludec, an ultra long-acting basal insulin, to insuli” View full resource at drugs.com
Most Recently Shared on December 23, 2010 at 6:01 pm By:
Drugs and Devices OW OW Health
Degludec significantly reduces risk of hypoglycaemia during the night compared to insulin glargine in two ... http://bit.ly/gL7ttd #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
News-Medical.Net
Stay up to date with the latest Obesity news and research via News-Medical.Net
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
